Overview
Specialty pharmaceutical company developing intranasal delivery formulations of psychedelic compounds including psilocybin and ketamine for rapid onset psychiatric treatment. Their proprietary nasal delivery technology improves bioavailability and dose precision.
More in Psychedelics
Latest industry news
Tianjin University Unveils a 3-Gram Non-Invasive BCI That Disappears Into Your Hair
2026-10-04 ยท Research
Neuralink Pretrained on 50,000 Hours of Unlabeled Brain Data โ and the Implications Are Enormous
2026-10-03 ยท Research
BlueWind Medical Wins Category I CPT Code for Subfascial Tibial Neuromodulation
2026-10-02 ยท Policy
Neurable One Brings Brain-Computer Interface Technology to Consumer Wireless Headphones
2026-10-01 ยท Product
Company details
Category
๐ Psychedelics
Location
San Diego, CA, USA
Funding
Seed ยท $4M
Website
neuronasal.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ